Rabeprazole Protection of Aspirin Induced Gastric Damage.
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of rabeprazole in preventing or decreasing acute
gastroduodenal injury caused by therapeutic doses of aspirin in a placebo-controlled,
randomized, double-blind parallel group study.